Extended-spectrum β-lactamases and the permeability barrier

被引:111
作者
Martinez-Martinez, L. [1 ]
机构
[1] Univ Hosp Marques Valdecilla, Microbiol Serv, Santander, Spain
关键词
Enterobacteriaceae; extended-spectrum beta-lactamases; outer membrane; permeability; porin; review;
D O I
10.1111/j.1469-0691.2007.01860.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The outer membrane of Gram-negative bacteria represents a barrier for penetration of hydrophilic compounds. Loss of porins (water-filled protein channels) contributes to antimicrobial resistance, particularly when additional mechanisms of resistance are expressed. Many studies on the structure and regulation of porins in Escherichia coli K-12 are available, but there is little information concerning clinical isolates of this species. In Klebsiella pneumoniae, two major porins, OmpK35 and OmpK36, are produced, but many extended-spectrum P-lactamase (ESBL)-producing K. pneumoniae isolates do not express OmpK35. Loss of both OmpK35 and OmpK36 in ESBL-producing K. pneumoniae causes resistance to cefoxitin, increased resistance to expanded-spectrum cephalosporins, and decreased susceptibility to carbapenems, particularly ertapenem. Porin loss also decreases the susceptibility to other non-p-lactam compounds, such as fluoroquinolones, of ESBL-producing organisms.
引用
收藏
页码:82 / 89
页数:8
相关论文
共 41 条
  • [1] ALBERTI S, 1995, INFECT IMMUN, V63, P903
  • [2] Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems
    Ardanuy, C
    Liñares, J
    Domínguez, MA
    Hernández-Allés, S
    Benedi, VJ
    Martínez-Martínez, L
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (07) : 1636 - 1640
  • [3] Omp35, a new Enterobacter aerogenes porin involved in selective susceptibility to cephalosporins
    Bornet, C
    Saint, N
    Fetnaci, L
    Dupont, M
    Davin-Régli, A
    Bollet, C
    Pagès, JM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (06) : 2153 - 2158
  • [4] Comparative aspects of the diffusion of norfloxacin, cefepime and spermine through the F porin channel of Enterobacter cloacae
    Chevalier, J
    Malléa, M
    Pagès, JM
    [J]. BIOCHEMICAL JOURNAL, 2000, 348 (pt 1) : 223 - 227
  • [5] CROSS-RESISTANCE TO FLUOROQUINOLONES IN MULTIPLE-ANTIBIOTIC-RESISTANT (MAR) ESCHERICHIA-COLI SELECTED BY TETRACYCLINE OR CHLORAMPHENICOL - DECREASED DRUG ACCUMULATION ASSOCIATED WITH MEMBRANE-CHANGES IN ADDITION TO OMPF REDUCTION
    COHEN, SP
    MCMURRY, LM
    HOOPER, DC
    WOLFSON, JS
    LEVY, SB
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) : 1318 - 1325
  • [6] DIFFUSION OF MEROPENEM AND IMIPENEM THROUGH THE OUTER-MEMBRANE OF ESCHERICHIA-COLI-K-12 AND CORRELATION WITH THEIR ANTIBACTERIAL ACTIVITIES
    CORNAGLIA, G
    GUAN, LM
    FONTANA, R
    SATTA, G
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (09) : 1902 - 1908
  • [7] Expression of SHV-2 β-lactamase and of reduced amounts of OmpK36 porin in Klebsiella pneumoniae results in increased resistance to cephalosporins and carbapenems
    Crowley, B
    Benedí, VJ
    Doménech-Sánchez, A
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) : 3679 - 3682
  • [8] A new mechanism of antibiotic resistance in Enterobacteriaceae induced by a structural modification of the major porin
    Dé, E
    Baslé, A
    Jaquinod, M
    Saint, N
    Malléa, M
    Molle, G
    Pagès, JM
    [J]. MOLECULAR MICROBIOLOGY, 2001, 41 (01) : 189 - 198
  • [9] Activity of nine antimicrobial agents against clinical isolates of Klebsiella pneumoniae producing extended-spectrum β-lactamases and deficient or not in porins
    Doménech-Sánchez, A
    Pascual, A
    Suárez, AI
    Alvarez, D
    Benedí, VJ
    Martínez-Martínez, L
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (05) : 858 - 860
  • [10] Role of Klebsiella pneumoniae OmpK35 porin in antimicrobial resistance
    Doménech-Sánchez, A
    Martínez-Martínez, L
    Hernández-Allés, S
    Canejo, MD
    Pascual, A
    Tomás, JM
    Albertí, S
    Benedí, VJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (10) : 3332 - 3335